Journal article

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.

Abstract:: Background

Patients with obstructive left main coronary artery disease are usually treated with coronary-artery bypass grafting (CABG). Randomized trials have suggested that drug-eluting stents may be an acceptable alternative to CABG in selected patients with left main coronary disease.

Methods

We randomly assigned 1905 eligible patients with left main coronary artery disease of low or intermediate anatomical complexity to undergo either percutaneous coronary int...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Stone, G. W., Sabik, J. F., Serruys, P. W., Simonton, C. A., Généreux, P., Puskas, J., Kandzari, D. E., Morice, M. C., Lembo, N., Brown, W. M., Taggart, D. P., Banning, A., Merkely, B., Horkay, F., Boonstra, P. W., van Boven, A. J., Ungi, I., Bogáts, G., Mansour, S., … Kappetein, A. P. (2016). Everolimus-eluting stents or bypass surgery for left main coronary artery disease. New England Journal of Medicine, 375(23), 2223–2235.

MLA Style

Stone, G. W., et al. “Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.” New England Journal of Medicine, vol. 375, no. 23, Massachusetts Medical Society, 2016, pp. 2223–35.

Chicago Style

Stone, GW, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, DE Kandzari, et al. 2016. “Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.” New England Journal of Medicine 375 (23): 2223–35.
Tweet
Print

Access Document

Files:: Banning et al, Everolimus-eluting stents or bypass surgery for...

(Preview, Version of record, pdf, 543.1KB, Terms of use)

Publisher copy:: 10.1056/nejmoa1610227

Authors

+ Stone, GW More by this author

Role:

Author

+ Sabik, JF More by this author

Role:

Author

+ Serruys, PW More by this author

Role:

Author

+ Simonton, CA More by this author

Role:

Author

+ Généreux, P More by this author

Role:

Author

More authors...

Funding

+ Abbott Vascular More from this funder

Bibliographic Details

Publisher:: Massachusetts Medical Society
Journal:: New England Journal of Medicine More from this journal
Volume:: 375
Issue:: 23
Pages:: 2223-2235
Publication date:: 2016-10-01
Acceptance date:: 2016-10-01
DOI:: 10.1056/nejmoa1610227
EISSN:: 1533-4406
ISSN:: 0028-4793
Pmid:: 27797291

Item Description

Language:: English
Keywords:: Coronary Artery Disease

Everolimus

Aged

EXCEL Trial Investigators

Kaplan-Meier Estimate

Male

Female

Drug-Eluting Stents

Percutaneous Coronary Intervention

Coronary Artery Bypass

Middle Aged

Humans
Pubs id:: pubs:656843
UUID:: uuid:f31a2085-f0ae-4f10-b669-df9319be19b7
Local pid:: pubs:656843
Source identifiers:: 656843
Deposit date:: 2017-11-16

Terms of use

Copyright holder:: Massachusetts Medical Society
Copyright date:: 2016
Notes:: Copyright © 2016 Massachusetts Medical Society. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP